GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hubei Biocause Heilen Pharmaceutical Co Ltd (SZSE:301211) » Definitions » Net Income Including Noncontrolling Interests

Hubei Biocause Heilen Pharmaceutical Co (SZSE:301211) Net Income Including Noncontrolling Interests : ¥173.6 Mil (TTM As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Hubei Biocause Heilen Pharmaceutical Co Net Income Including Noncontrolling Interests?

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Hubei Biocause Heilen Pharmaceutical Co's Net Income Including Noncontrolling Interests for the three months ended in Mar. 2024 was ¥37.4 Mil. Its Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Mar. 2024 was ¥173.6 Mil.

Hubei Biocause Heilen Pharmaceutical Co Net Income Including Noncontrolling Interests Historical Data

The historical data trend for Hubei Biocause Heilen Pharmaceutical Co's Net Income Including Noncontrolling Interests can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hubei Biocause Heilen Pharmaceutical Co Net Income Including Noncontrolling Interests Chart

Hubei Biocause Heilen Pharmaceutical Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Income Including Noncontrolling Interests
Get a 7-Day Free Trial 184.62 168.07 121.65 125.79 176.12

Hubei Biocause Heilen Pharmaceutical Co Quarterly Data
Dec18 Jun19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Income Including Noncontrolling Interests Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 39.92 73.12 31.48 31.60 37.38

Hubei Biocause Heilen Pharmaceutical Co Net Income Including Noncontrolling Interests Calculation

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥173.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hubei Biocause Heilen Pharmaceutical Co Net Income Including Noncontrolling Interests Related Terms

Thank you for viewing the detailed overview of Hubei Biocause Heilen Pharmaceutical Co's Net Income Including Noncontrolling Interests provided by GuruFocus.com. Please click on the following links to see related term pages.

Hubei Biocause Heilen Pharmaceutical Co (SZSE:301211) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hubei Biocause Heilen Pharmaceutical Co Ltd (SZSE:301211) » Definitions » Net Income Including Noncontrolling Interests
Comparable Companies
SZSE:300683 SZSE:300158 SHSE:600351 SZSE:301509 SHSE:603367 SZSE:301089 SZSE:002793 SHSE:688553 SHSE:600789 SHSE:605199 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
No. 122, Yangwan Road, Dadao District, Jingmen High-tech Zone, Hubei Province, Jingmen, CHN, 448000
Website
http://www.biocause.com
Hubei Biocause Heilen Pharmaceutical Co Ltd is engaged in the research and development, production and sales of chemical raw materials and preparation products.

Hubei Biocause Heilen Pharmaceutical Co (SZSE:301211) Headlines

No Headlines